On the other hand, SPL disrupts S1P-induced tumorigenesis and malignant progression, fibrosis and aberrant angiogenesis[33] and loss of SPL expression is significantly associated with aggressive cancers[32, 37]. The gene discussed is SGPL1; the disease is cancer.